Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO, April 22, 2024 -- Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives...